CervoMed Inc.
CRVO
Rank in Stocks
#26186
CervoMed Inc., a clinical-stage biotechnology company, engages in the... CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood–brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Share Price
$1.43
Last synced: 2026-11-09
Market Cap
$21.62M
Change (1 day)
0.70%
Change (1 year)
-80.70%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade CervoMed Inc. (CRVO)
Category
Healthcare
Operating Margin for CervoMed Inc. (CRVO)
Operating Margin as of November 2026 TTM: -9,661.43%
According to CervoMed Inc.'s latest financial reports, its current operating margin (TTM) is -9,661.43%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for CervoMed Inc. from 2005 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -9,661.43% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | -100.00% |
| 2013 | -11,039.95% | 250.65% |
| 2012 | -3,148.38% | 9.32% |
| 2011 | -2,879.88% | -84.84% |
| 2010 | -19,002.71% | 0.00% |
| 2009 | 0.00% | -100.00% |
| 2008 | -5,528.88% | 491.92% |
| 2007 | -934.06% | 0.00% |
| 2006 | 0.00% | 0.00% |
| 2005 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.00% |
US
|
|
| -149.01% | -99.98% |
US
|
|
| 25.57% | -100.00% |
AU
|
|
| 31.23% | -100.00% |
BE
|
|
| 29.35% | -100.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about CervoMed Inc.'s operating margin
What is CervoMed Inc.'s operating margin?
CervoMed Inc.'s operating margin is -9,661.43%, as of Nov 2026.
What was CervoMed Inc.'s operating margin in 2025?
In 2025, CervoMed Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has CervoMed Inc.'s operating margin changed since 2020?
From 2020 to 2025, CervoMed Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2025 (0.00%).
How does CervoMed Inc.'s operating margin compare with similar companies?
CervoMed Inc.'s operating margin (-9,661.43%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.